Eph receptors as therapeutic targets in glioblastoma

por Day, B W, Stringer, B W, Boyd, A W
Publicado 2014

Consultations for refractory cases in mental health services: a descriptive study

por Stringer, B., Mocking, R. J. T., Rammers, D., Koekkoek, B.
Publicado 2023

Vascular changes in early TSH-induced thyroid tumours in the rat.

por Wynford-Thomas, D., Stringer, B. M., Gomez Morales, M., Williams, E. D.
Publicado 1983

Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways

por Hallal, S., Mallawaaratchy, D. M., Wei, H., Ebrahimkhani, S., Stringer, B. W., Day, B. W., Boyd, A. W., Guillemin, G. J., Buckland, M. E., Kaufman, Kimberley L.
Publicado 2018

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma

por Greenall, S A, Lim, Y C, Mitchell, C B, Ensbey, K S, Stringer, B W, Wilding, A L, O'Neill, G M, McDonald, K L, Gough, D J, Day, B W, Johns, T G
Publicado 2017

Patient-derived glioblastoma cells show significant heterogeneity in treatment responses to the inhibitor-of-apoptosis-protein antagonist birinapant

por Zakaria, Z, Tivnan, A, Flanagan, L, Murray, D W, Salvucci, M, Stringer, B W, Day, B W, Boyd, A W, Kögel, D, Rehm, M, O'Brien, D F, Byrne, A T, Prehn, J H M
Publicado 2016